NCT01231425

Brief Summary

The purpose of this study is to evaluate prospectively the effectiveness of acupuncture as adjunctive therapy in the treatment of spinal pain is the three backbone areas: cervical, thoracic and lumbar pain, under conditions of usual clinical practice as the medical acupuncturist performed acupuncture, with and without supplementary pharmacological treatment during the first 4 weeks of follow up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 28, 2010

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 1, 2010

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

November 8, 2011

Status Verified

November 1, 2011

Enrollment Period

1.9 years

First QC Date

September 28, 2010

Last Update Submit

November 7, 2011

Conditions

Keywords

Back paincervicalgiadorsalgialumbalgiaacupuncture

Outcome Measures

Primary Outcomes (1)

  • VAS: Visual Analogic Scale of pain

    Pain assesment will be evaluated using a Visual Analogic Scale of pain (VAS). This variable will be evaluated in all 10 visits and it will be showed its evolution (decrease) along the study

    10 weekly visits

Secondary Outcomes (5)

  • Sheehan Disability Questionnaire

    First Visit (week 1) and Final Visit (week 10)

  • Evaluation of the Scale Hospital Anxiety Depression (HAD)

    First Visit (week 1) and Final Visit (week 10)

  • Health Questionnaire EuroQol-5D

    First Visit (week 1) and Final Visit (week 10)

  • Assessment of sleep with the integrated scale MOS (Medical Outcomes Study)

    First Visit (week 1) and Final Visit (week 10)

  • McGill Pain Questionnaire

    10 weekly visits

Study Arms (2)

With usual concomitant treatment

Two observational cohorts of patients will be evaluated: with and without concomitant analgesic/ antiinflammatory drugs. The objective is evaluate that both therapies (drugs and acupuncture) could be used as adjunctive therapy in order to maximize the analgesia that could be reached

Without usual concomitant treatment

This group include patients that are not been treated with analgesic drugs at the beginning of the study. As an observational and naturalistic study any indicated treatment is allowed in any time

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is patients who go to the Acupuncture Office diagnosed of cervical, thoracic or lumbar pain caused by musculoskeletal diseases, pretreated with pharmacological treatment, they start treatment with acupuncture as adjunctive therapy for symptoms of their disease. Initially it was estimated that the optimal number of patients included to achieve the objectives of the study is 102 patients

You may qualify if:

  • Patients of both sexes, aged 18 and over
  • Patients diagnosed with back pain: cervical, thoracic or lumbar.
  • Patients who has received appropriate medical treatment for their disease: analgesics, anti-inflammatories, or other treatments, but painful and symptoms persist
  • Patients that could receive acupuncture treatment in order to reduce the symptoms and reviewed by a medical acupuncturist
  • Patients with sufficient cultural and educational level to complete the health questionnaires required in the study
  • Patients who have given their written informed consent to participate in the study

You may not qualify if:

  • Patient with any illness and that medical opinions recommended not to participate in the study
  • Patient can not respond to questionnaires administered during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

I.H. Hospital San Jose

Madrid, Madrid, 20010, Spain

Location

MeSH Terms

Conditions

Back PainMusculoskeletal DiseasesNeck PainLow Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Valentin Martin, MD, PhD

    Grupo G6

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2010

First Posted

November 1, 2010

Study Start

July 1, 2010

Primary Completion

June 1, 2012

Study Completion

October 1, 2012

Last Updated

November 8, 2011

Record last verified: 2011-11

Locations